MMSI Stock Gains Following Latest Merger to Boost Hemostasis PortfolioZacks Investment Research • 05/21/25
Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable EndoprosthesisGlobeNewsWire • 05/06/25
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) TrialGlobeNewsWire • 05/05/25
MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins UpZacks Investment Research • 04/25/25
Compared to Estimates, Merit Medical (MMSI) Q1 Earnings: A Look at Key MetricsZacks Investment Research • 04/24/25
What Analyst Projections for Key Metrics Reveal About Merit Medical (MMSI) Q1 EarningsZacks Investment Research • 04/21/25
Merit Medical (MMSI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 04/17/25
Merit Medical Stock Slips Despite the Launch of New Ventrax SystemZacks Investment Research • 04/15/25
4 Stocks to Watch as Dental Supplies Recovers Amid Tariff HeadwindZacks Investment Research • 04/14/25
Merit Medical (MMSI) Surges 8.3%: Is This an Indication of Further Gains?Zacks Investment Research • 04/10/25
Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025GlobeNewsWire • 04/07/25
Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERDGlobeNewsWire • 03/27/25
Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong ResultsZacks Investment Research • 03/26/25
Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)GlobeNewsWire • 03/25/25
MMSI Announces Commencement of Patient Enrollment in PREEMIE StudyZacks Investment Research • 03/14/25